A Brief History of Profound Medical Corp. (PROF)

Profound Medical Corp. is a Canadian medical technology company that focuses on developing and commercializing innovative therapies for the treatment of prostate cancer and other diseases. The company was founded in 2008 and is headquartered in Mississauga, Ontario.

Here are some key milestones in the history of Profound Medical Corp.:

• 2011: Profound Medical Corp. completed its initial public offering (IPO) on the Toronto Stock Exchange, raising funds to support the development of its technology platform.
• 2013: The company received approval from the U.S. Food and Drug Administration (FDA) to begin clinical trials for its TULSA-PRO system, a minimally invasive treatment for prostate cancer.
• 2016: Profound Medical Corp. announced positive results from its TACT Trial, demonstrating the safety and efficacy of the TULSA-PRO system in treating prostate cancer patients.
• 2018: The company received FDA clearance for the TULSA-PRO system, allowing for commercialization in the United States.
• 2020: Profound Medical Corp. expanded its reach in Europe, receiving CE Mark approval for the TULSA-PRO system to be used in the treatment of localized prostate cancer.

Who Owns Profound Medical Corp. (PROF)

Profound Medical Corp. (PROF) is a medical technology company that specializes in developing and commercializing novel technologies to target and treat prostate cancer and other diseases. The ownership structure of Profound Medical Corp. is as follows:

• Institutional Investors: Institutional investors own a significant portion of Profound Medical Corp., including mutual funds, pension funds, and other institutional entities. These investors often provide stability and long-term support for the company.
• Management Team: The management team of Profound Medical Corp. likely holds a considerable amount of ownership in the company. This can include the CEO, CFO, and other executives who are responsible for the day-to-day operations and strategic direction of the company.
• Individual Investors: Individual investors, including retail investors and high-net-worth individuals, may also own shares of Profound Medical Corp. These investors contribute to the liquidity and trading volume of the company's stock.
• Venture Capitalists: Venture capitalists may have invested in Profound Medical Corp. during its early stages of growth, providing capital and expertise to help the company expand and develop its technology.

Overall, Profound Medical Corp. is owned by a diverse group of investors, including institutional investors, the management team, individual investors, and venture capitalists. This ownership structure reflects the company's appeal to a wide range of stakeholders who are interested in the innovative medical technologies being developed by Profound Medical Corp.

Profound Medical Corp. (PROF) Mission Statement

At Profound Medical Corp., our mission is to improve the lives of patients suffering from debilitating diseases through innovative medical technologies. We are committed to advancing the field of medicine by providing non-invasive, incision-free solutions that offer patients a better quality of life.

We believe in pushing the boundaries of medical technology to create new treatment options for patients with conditions such as prostate cancer and uterine fibroids. Our team of dedicated professionals works tirelessly to develop cutting-edge solutions that address the unmet needs of patients worldwide.

• Innovation: We strive to constantly innovate and improve our technologies to provide the best possible outcomes for patients.
• Compassion: We approach our work with empathy and compassion, always putting the needs of patients first.
• Collaboration: We believe in the power of collaboration and work closely with healthcare providers to ensure our technologies are accessible to those who need them.
• Integrity: We uphold the highest standards of integrity in everything we do, from our research and development processes to our interactions with patients and partners.

How Profound Medical Corp. (PROF) Works

Profound Medical Corp. is a medical technology company that specializes in developing and commercializing innovative medical devices to treat prostate cancer and other conditions. The company's flagship product is the TULSA-PRO system, which uses MRI-guided transurethral ultrasound ablation technology to target and treat diseased tissue while preserving healthy tissue.

Profound Medical Corp. works by partnering with leading medical institutions and healthcare providers to bring their technology to patients around the world. The company's team of experts, including engineers, scientists, and medical professionals, work together to design, develop, and manufacture their cutting-edge devices.

Here is how Profound Medical Corp. works:

• Research and Development: The company invests heavily in research and development to continuously improve their technology and develop new products.
• Clinical Trials: Before bringing a new product to market, Profound Medical Corp. conducts clinical trials to ensure its safety and efficacy. These trials are conducted in collaboration with leading medical institutions and researchers.
• Regulatory Approval: Once a product has demonstrated its safety and effectiveness, Profound Medical Corp. seeks regulatory approval from health authorities in various countries.
• Commercialization: After receiving regulatory approval, Profound Medical Corp. works with healthcare providers to commercialize their products and make them available to patients in need.

Profound Medical Corp. is dedicated to improving the lives of patients with prostate cancer and other conditions through their innovative medical devices and technology. With a strong focus on research, development, and collaboration, the company continues to make strides in the field of medical technology.

How Profound Medical Corp. (PROF) Makes Money

Profound Medical Corp. is a medical technology company that specializes in developing and commercializing innovative, non-invasive procedures for the treatment of prostate cancer and other diseases. The company generates revenue through a few key avenues:

• Product Sales: One of the primary ways Profound Medical Corp. makes money is through the sale of its medical devices. The company offers a range of products, including the TULSA-PRO system, which is used for the ablation of prostate tissue. These products are sold to hospitals, clinics, and other healthcare providers.
• Service Revenue: In addition to selling medical devices, Profound Medical Corp. also generates revenue through the provision of services. This includes training healthcare providers on how to use its products effectively, as well as providing ongoing support and maintenance.
• Licensing and Royalties: Profound Medical Corp. has also entered into licensing agreements with other companies in the medical technology space. Through these agreements, the company earns royalties on sales of products that incorporate its patented technology.
• Clinical Trial Participation: Another source of revenue for Profound Medical Corp. is participation in clinical trials. The company's technology is often used in research studies to evaluate its effectiveness in treating various conditions. Profound Medical Corp. receives compensation for its involvement in these trials.